Published in Int J Mol Sci on January 28, 2013
A simple method for displaying the hydropathic character of a protein. J Mol Biol (1982) 150.65
A century of Alzheimer's disease. Science (2006) 5.84
EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers. Nat Struct Mol Biol (2008) 5.32
Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct. Science (2001) 4.48
A century-old debate on protein aggregation and neurodegeneration enters the clinic. Nature (2006) 3.76
Molecular-level secondary structure, polymorphism, and dynamics of full-length alpha-synuclein fibrils studied by solid-state NMR. Proc Natl Acad Sci U S A (2005) 3.37
The fold of alpha-synuclein fibrils. Proc Natl Acad Sci U S A (2008) 2.82
Investigation of alpha-synuclein fibril structure by site-directed spin labeling. J Biol Chem (2007) 2.30
The flavonoid baicalein inhibits fibrillation of alpha-synuclein and disaggregates existing fibrils. J Biol Chem (2004) 2.02
Rifampicin inhibits alpha-synuclein fibrillation and disaggregates fibrils. Chem Biol (2004) 1.91
FindPept, a tool to identify unmatched masses in peptide mass fingerprinting protein identification. Proteomics (2002) 1.83
Small molecule inhibitors of alpha-synuclein filament assembly. Biochemistry (2006) 1.69
The flavanol (-)-epigallocatechin 3-gallate inhibits amyloid formation by islet amyloid polypeptide, disaggregates amyloid fibrils, and protects cultured cells against IAPP-induced toxicity. Biochemistry (2010) 1.63
Peptide-based inhibitors of amyloid assembly. Methods Enzymol (2006) 1.44
Inhibition of amyloid formation. J Mol Biol (2012) 1.36
Caught in the act: alpha-synuclein is the culprit in Parkinson's disease. Neuron (2003) 1.33
Antioxidant compounds have potent anti-fibrillogenic and fibril-destabilizing effects for alpha-synuclein fibrils in vitro. J Neurochem (2006) 1.27
Dopamine and L-dopa disaggregate amyloid fibrils: implications for Parkinson's and Alzheimer's disease. FASEB J (2004) 1.13
Impact of Tyr to Ala mutations on alpha-synuclein fibrillation and structural properties. Biochim Biophys Acta (2008) 1.02
Human serum albumin as an antioxidant in the oxidation of (-)-epigallocatechin gallate: participation of reversible covalent binding for interaction and stabilization. Biosci Biotechnol Biochem (2011) 1.01
The sulfated triphenyl methane derivative acid fuchsin is a potent inhibitor of amyloid formation by human islet amyloid polypeptide and protects against the toxic effects of amyloid formation. J Mol Biol (2010) 1.00
A novel inhibitor of amyloid β (Aβ) peptide aggregation: from high throughput screening to efficacy in an animal model of Alzheimer disease. J Biol Chem (2012) 0.98
Vitamin A exhibits potent antiamyloidogenic and fibril-destabilizing effects in vitro. Exp Neurol (2004) 0.91
Alpha-synuclein dysfunction in Lewy body diseases. Mov Disord (2005) 0.90
Modulating self-assembly of amyloidogenic proteins as a therapeutic approach for neurodegenerative diseases: strategies and mechanisms. ChemMedChem (2012) 0.89
Pyrroloquinoline quinone inhibits the fibrillation of amyloid proteins. Prion (2010) 0.86
Pyrroloquinoline quinone (PQQ) prevents fibril formation of alpha-synuclein. Biochem Biophys Res Commun (2006) 0.85
Toward the discovery of effective polycyclic inhibitors of alpha-synuclein amyloid assembly. J Biol Chem (2011) 0.82
Vitamin A potently destabilizes preformed alpha-synuclein fibrils in vitro: implications for Lewy body diseases. Neurobiol Dis (2006) 0.78
Novel electrochemical sensor system for protein using the aptamers in sandwich manner. Biosens Bioelectron (2005) 1.09
Cloning and functional expression of glucose dehydrogenase complex of Burkholderia cepacia in Escherichia coli. J Biotechnol (2005) 1.04
Review of glucose oxidases and glucose dehydrogenases: a bird's eye view of glucose sensing enzymes. J Diabetes Sci Technol (2011) 1.03
Screening and improvement of an anti-VEGF DNA aptamer. Molecules (2010) 1.00
Wireless enzyme sensor system for real-time monitoring of blood glucose levels in fish. Biosens Bioelectron (2008) 0.97
Glucose enzyme electrode using cytochrome b(562) as an electron mediator. Biosens Bioelectron (2003) 0.97
In silico panning for a non-competitive peptide inhibitor. BMC Bioinformatics (2007) 0.96
Uniform molecularly imprinted microspheres and nanoparticles prepared by precipitation polymerization: the control of particle size suitable for different analytical applications. Anal Chim Acta (2006) 0.95
Active site analysis of fructosyl amine oxidase using homology modeling and site-directed mutagenesis. Biotechnol Lett (2006) 0.94
Aptamer selection based on inhibitory activity using an evolution-mimicking algorithm. Biochem Biophys Res Commun (2006) 0.92
Engineering PQQ glucose dehydrogenase with improved substrate specificity. Site-directed mutagenesis studies on the active center of PQQ glucose dehydrogenase. Biomol Eng (2004) 0.92
Engineering of ligand specificity of periplasmic binding protein for glucose sensing. Biotechnol Lett (2008) 0.91
Selection of DNA aptamer against prostate specific antigen using a genetic algorithm and application to sensing. Biosens Bioelectron (2010) 0.91
Selection of DNA aptamers against VEGF165 using a protein competitor and the aptamer blotting method. Biotechnol Lett (2008) 0.90
Stabilization of quaternary structure of water-soluble quinoprotein glucose dehydrogenase. Mol Biotechnol (2003) 0.90
Increasing stability of water-soluble PQQ glucose dehydrogenase by increasing hydrophobic interaction at dimeric interface. BMC Biochem (2005) 0.90
A novel wireless glucose sensor employing direct electron transfer principle based enzyme fuel cell. Biosens Bioelectron (2006) 0.89
Construction of engineered fructosyl peptidyl oxidase for enzyme sensor applications under normal atmospheric conditions. Biotechnol Lett (2011) 0.89
Relaxin ameliorates salt-sensitive hypertension and renal fibrosis. Nephrol Dial Transplant (2011) 0.89
A screening method for DNA aptamers that bind to a specific, unidentified protein in tissue samples. Biotechnol Lett (2006) 0.88
Engineering of a green-light inducible gene expression system in Synechocystis sp. PCC6803. Microb Biotechnol (2013) 0.88
The construction of a glucose-sensing luciferase. Biosens Bioelectron (2009) 0.87
Screening of Aspergillus-derived FAD-glucose dehydrogenases from fungal genome database. Biotechnol Lett (2011) 0.87
Electrochemical protein chip with arrayed immunosensors with antibodies immobilized in a plasma-polymerized film. Anal Chem (2003) 0.87
Biofuel cell system employing thermostable glucose dehydrogenase. Biotechnol Lett (2008) 0.86
Peptide ligand screening of alpha-synuclein aggregation modulators by in silico panning. BMC Bioinformatics (2007) 0.86
Pyrroloquinoline quinone inhibits the fibrillation of amyloid proteins. Prion (2010) 0.86
Improving the gene-regulation ability of small RNAs by scaffold engineering in Escherichia coli. ACS Synth Biol (2013) 0.86
Pyrroloquinoline quinone (PQQ) prevents fibril formation of alpha-synuclein. Biochem Biophys Res Commun (2006) 0.85
BioCapacitor--a novel category of biosensor. Biosens Bioelectron (2008) 0.85
A flow method with photocatalytic oxidation of dissolved organic matter using a solid-phase (TiO2) reactor followed by amperometric detection of consumed oxygen. Anal Chem (2002) 0.85
Functional expression of Phanerochaete chrysosporium cellobiose dehydrogenase flavin domain in Escherichia coli. Biotechnol Lett (2010) 0.85
Cloning and expression of the gene encoding catalytic subunit of thermostable glucose dehydrogenase from Burkholderia cepacia in Escherichia coli. Biochim Biophys Acta (2003) 0.84
Engineering fructosyl peptide oxidase to improve activity toward the fructosyl hexapeptide standard for HbA1c measurement. Mol Biotechnol (2013) 0.84
Engineering of dye-mediated dehydrogenase property of fructosyl amino acid oxidases by site-directed mutagenesis studies of its putative proton relay system. Biotechnol Lett (2010) 0.84
Exploration of structural features of monomeric helical peptides designed with a genetic algorithm. Proteins (2003) 0.84
Isolation and characterization of a fructosyl-amine oxidase from an Arthrobacter sp. Biotechnol Lett (2005) 0.84
Study of the role of anaerobic metabolism in succinate production by Enterobacter aerogenes. Appl Microbiol Biotechnol (2014) 0.84
Selection of DNA aptamers that recognize α-synuclein oligomers using a competitive screening method. Anal Chem (2012) 0.83
Production of hydrogen and methane from organic solid wastes by phase-separation of anaerobic process. Bioresour Technol (2006) 0.83
Aptameric enzyme subunit for biosensing based on enzymatic activity measurement. Anal Chem (2006) 0.83
Design of riboregulators for control of cyanobacterial (Synechocystis) protein expression. Biotechnol Lett (2013) 0.83
Molecular engineering of PQQGDH and its applications. Arch Biochem Biophys (2004) 0.83
Engineered alpha-synuclein prevents wild type and familial Parkin variant fibril formation. Biochem Biophys Res Commun (2005) 0.83
Single nucleotide polymorphism typing on DNA array with hydrophobic surface fabricated by plasma-polymerization technique. Biosens Bioelectron (2004) 0.82
Site directed mutagenesis studies of FAD-dependent glucose dehydrogenase catalytic subunit of Burkholderia cepacia. Biotechnol Lett (2008) 0.82
Characterization and application of aptamers for Taq DNA polymerase selected using an evolution-mimicking algorithm. Biotechnol Lett (2006) 0.82
Motif-based search for a novel fructosyl peptide oxidase from genome databases. Biotechnol Bioeng (2010) 0.82
Affinity improvement of a VEGF aptamer by in silico maturation for a sensitive VEGF-detection system. Anal Chem (2012) 0.82
Fluorescent-ligand-mediated screening of G-quadruplex structures using a DNA microarray. Angew Chem Int Ed Engl (2013) 0.82
Selection of DNA aptamers against insulin and construction of an aptameric enzyme subunit for insulin sensing. Biosens Bioelectron (2008) 0.82
Development of a flow-injection analysis (FIA) enzyme sensor for fructosyl amine monitoring. Anal Bioanal Chem (2002) 0.82
High-rate thermophilic methane fermentation on short-chain fatty acids in a down-flow anaerobic packed-bed reactor. Bioprocess Biosyst Eng (2004) 0.81
Homogeneous DNA sensing using enzyme-inhibiting DNA aptamers. Biochem Biophys Res Commun (2006) 0.81
The simple and rapid detection of specific PCR products from bacterial genomes using Zn finger proteins. Nucleic Acids Res (2008) 0.81
Development of fructosyl amine oxidase specific to fructosyl valine by site-directed mutagenesis. Protein Eng Des Sel (2008) 0.81
Kinetic mechanism and inhibitor characterization of WNK1 kinase. Biochemistry (2009) 0.81
Construction of mutant glucose oxidases with increased dye-mediated dehydrogenase activity. Int J Mol Sci (2012) 0.81
Screening of DNA aptamer against mouse prion protein by competitive selection. Prion (2007) 0.81
SocA is a novel periplasmic binding protein for fructosyl amino acid. Biochem Biophys Res Commun (2005) 0.80
Drug-induced isolated visceral angioneurotic edema. Intern Med (2005) 0.80
The effect of amino acid substitution in the imperfect repeat sequences of alpha-synuclein on fibrillation. Biochim Biophys Acta (2009) 0.80
DNA aptamers against the Cry j 2 allergen of Japanese cedar pollen for biosensing applications. Biosens Bioelectron (2015) 0.80
Review of fructosyl amino acid oxidase engineering research: a glimpse into the future of hemoglobin A1c biosensing. J Diabetes Sci Technol (2009) 0.80
Improved substrate specificity of water-soluble pyrroloquinoline quinone glucose dehydrogenase by a peptide ligand. Biotechnol Lett (2003) 0.80
Effect of reparation of repeat sequences in the human alpha-synuclein on fibrillation ability. Int J Biol Sci (2006) 0.80
Direct electron transfer type disposable sensor strip for glucose sensing employing an engineered FAD glucose dehydrogenase. Enzyme Microb Technol (2012) 0.79
Aptameric sensors based on structural change for diagnosis. Faraday Discuss (2011) 0.79
W-motif exchange between beta-propeller proteins. Protein J (2007) 0.79
The inhibitory effect of pyrroloquinoline quinone on the amyloid formation and cytotoxicity of truncated alpha-synuclein. Mol Neurodegener (2010) 0.79
Semi-automated bacterial spore detection system with micro-fluidic chips for aerosol collection, spore treatment and ICAN DNA detection. Biosens Bioelectron (2009) 0.79